Loading...
Loading...
Chapter 30 (Pharmaceutical Products) ยท Heading 3002 (Blood, antisera, vaccines, toxins, microorganisms and similar products) ยท Last updated: April 2026 ยท Source: Indian Customs (DGFT) Records
HS Code 30029090.0 (Other blood products, toxins, cultures of micro-organisms) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $525.0K across 44 shipments, this code covers 2 distinct pharmaceutical products exported by 8 Indian manufacturers to 12 countries. The leading product under this classification is Diagnostic at $262.6K, followed by Reagent.
The top importing markets include Germany, Japan, China. The top 5 products account for 100.0% of total trade under this code. Average transaction value is $11.9K. Leading exporters include ROCHE DIAGNOSTICS INTERNATIONAL LTD and GUANGZHOU WONDFO BIOTECH CO LIMITED. Data sourced from Indian Customs (DGFT) shipping bill records.

2 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Diagnostic | $262.6K | 23 | $14.71 | 4 |
| #2 | Reagent | $262.4K | 21 | $15.63 | 3 |
12 countries import products classified under HS Code 30029090.0 from India
Indian pharmaceutical exports under HS Code 30029090.0 reach 12 countries worldwide. The largest importer is Germany ($3.4M), followed by Japan ($2.3M), China ($2.1M), United States ($1.9M). This geographic spread reflects India's position as the world's largest supplier of generic pharmaceutical products by volume.
| Rank | Country | Trade Value | Market Share |
|---|---|---|---|
| #1 | Germany | $3.4M | 649.9% |
| #2 | Japan | $2.3M | 444.8% |
| #3 | China | $2.1M | 395.7% |
| #4 | United States | $1.9M | 361.6% |
| #5 | Italy | $1.8M | 344.6% |
| #6 | Sri Lanka | $1.2M |
8 Indian pharmaceutical manufacturers export under this classification
The Harmonized System (HS) is an internationally standardized system of names and numbers to classify traded products, used by over 200 countries for customs tariffs and trade statistics. HS Code 30029090.0 is an 8-digit Indian Customs Tariff (ITC-HS) code that precisely identifies products classified as "Other blood products, toxins, cultures of micro-organisms".
The first 6 digits (300290) are standardized by the World Customs Organization (WCO) and used identically across all 200+ member countries. Digits 7-8 are India-specific subdivisions defined by the Directorate General of Foreign Trade (DGFT) for more granular classification of pharmaceutical exports. This code is declared on every shipping bill filed with Indian Customs for products matching this classification.
Correct classification under HS Code 30029090.0 is critical for customs clearance, duty assessment, and regulatory compliance. Misclassification can result in shipment delays, incorrect duty payments, and penalties from customs authorities.
As a Chapter 30 pharmaceutical product, HS Code 30029090.0 may qualify for preferential duty rates in many markets. WTO TRIPS provisions and bilateral FTAs (e.g., India-ASEAN, India-Japan CEPA) can significantly reduce applicable duties.
Indian exporters must declare HS Code 30029090.0 on shipping bills filed with DGFT. Pharmaceutical exports require Drug Controller General of India (DCGI) approval, Certificate of Pharmaceutical Product (COPP), and compliance with the Drugs & Cosmetics Act.
Products under this code destined for international procurement programs (UNICEF, Global Fund, PEPFAR) typically require WHO Prequalification. PQ status affects eligibility for preferential procurement and duty exemptions in recipient countries.
Each of the 12 importing countries has specific pharmaceutical registration requirements. Products must be registered with the national drug regulatory authority before customs clearance, regardless of HS code classification.
Access every individual shipping bill, supplier contacts, buyer details, and pricing trends for products classified under HS Code 30029090.0.
44+ individual bills of lading
8 exporters with contact details
12 importing countries
Common questions about HS Code 30029090.0, answered with data from Indian Customs records.
HS code 30029090.0 refers to "Other blood products, toxins, cultures of micro-organisms" under Chapter 30 (Pharmaceutical Products), Heading 3002 (Blood, antisera, vaccines, toxins, microorganisms and similar products) of the Harmonized System. In India's export trade, this code covers $525.0K in trade value across 44 shipments from 8 exporters to 12 countries.
2 distinct pharmaceutical products are exported from India under HS code 30029090.0. The top products include Diagnostic ($262.6K), Reagent ($262.4K). These cover a combined trade value of $525.0K.
The top importing countries for HS code 30029090.0 from India are Germany ($3.4M), Japan ($2.3M), China ($2.1M), United States ($1.9M), Italy ($1.8M). In total, Indian exporters ship products under this code to 12 countries worldwide.
The leading Indian exporters under HS code 30029090.0 include ROCHE DIAGNOSTICS INTERNATIONAL LTD ($458.3M), GUANGZHOU WONDFO BIOTECH CO LIMITED ($82.8M), DENKA COMPANY LIMITED ($47.7M). In total, 8 Indian exporters ship products under this classification.
Latest developments and market context
Detailed market intelligence for HS Code 30029090.0 โ including regulatory updates, trade policy changes, and competitive landscape analysis โ will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
This analysis is compiled from Indian Customs (DGFT) shipping bill records covering the period 2020โ2024. Each record includes the declared 8-digit ITC-HS code, product description, trade value (FOB USD), supplier name, buyer name, and destination country. Data is aggregated across all 2 pharmaceutical products classified under HS Code 30029090.0.
44
Shipment Records
2
Products
2020โ2024
Data Coverage
Apr 2026
Last Updated
Disclaimer: Trade data is sourced from publicly available Indian Customs records. Values represent FOB (Free On Board) prices in USD. Actual import values may differ due to CIF adjustments, currency fluctuations, and destination country customs valuation methods.
| 237.4% |
| #7 | Nigeria | $1.2M | 223.8% |
| #8 | Ethiopia | $1.1M | 204.9% |
| #9 | Spain | $1.1M | 200.0% |
| #10 | Russia | $520.9K | 99.2% |
| #11 | Kenya | $487.2K | 92.8% |
| #12 | United Arab Emirates | $408.0K | 77.7% |
Import duties for HS code 30029090.0 (Other blood products, toxins, cultures of micro-organisms) vary by destination country. As a Chapter 30 pharmaceutical product, many countries offer preferential or zero-duty rates for essential medicines under this code. The average transaction value from India is $11.9K, and importers should consult their national customs authority for applicable duty rates, exemptions, and regulatory requirements.
HS code 30029090.0 is an 8-digit Indian Customs Tariff (ITC-HS) code under Chapter 30 (Pharmaceutical Products), Heading 3002 (Blood, antisera, vaccines, toxins, microorganisms and similar products), Subheading 300290. The first 6 digits follow the international Harmonized System (WCO), while digits 7-8 are India-specific subdivisions used for customs and trade statistics.
India's total export trade under HS code 30029090.0 is $525.0K across 44 shipments. The average shipment value is $11.9K. The largest product category is Diagnostic at $262.6K.
HS code classifications follow the WCO Harmonized System. Verify tariff rates with your national customs authority.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Products Under This Code
8 exporters to 12 countries
Expert-Reviewed
By pharmaceutical trade specialists
Unlock shipment-level data, supplier contacts, and custom reports for HS Code 30029090.0.
Request Demo